ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $232,962 | +29.5% | 26,383 | +12.1% | 0.01% | +16.7% |
| Q4 2022 | $179,846 | +13.1% | 23,540 | +5.1% | 0.01% | +20.0% |
| Q3 2022 | $159,000 | -19.7% | 22,400 | -8.5% | 0.01% | -9.1% |
| Q2 2022 | $198,000 | -24.4% | 24,476 | +29.6% | 0.01% | -21.4% |
| Q1 2022 | $262,000 | -38.9% | 18,879 | +23.4% | 0.01% | -46.2% |
| Q4 2021 | $429,000 | -11.2% | 15,300 | +7.8% | 0.03% | -3.7% |
| Q3 2021 | $483,000 | -33.0% | 14,197 | -19.5% | 0.03% | -30.8% |
| Q2 2021 | $721,000 | +5.3% | 17,638 | +3.7% | 0.04% | 0.0% |
| Q1 2021 | $685,000 | -37.5% | 17,004 | -8.2% | 0.04% | -50.6% |
| Q4 2020 | $1,096,000 | -31.9% | 18,528 | -44.0% | 0.08% | +51.9% |
| Q3 2020 | $1,609,000 | – | 33,081 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |